Retina Society 2019 Annual Meeting
Sep 12, 2019
Podium Presentation: Interim 24-week Data from the OPTIC Trial: Phase 1 Study of Intravitreal Gene Therapy with ADVM-022 (AAV.7m8-aflibercept) for Neovascular (Wet) Age-related Macular Degeneration.
Date: September 12, 2019
Time:7:41 – 7:47 am BST
Location: The Landmark Hotel, London, UK
Speaker: Szilard Kiss, M.D., director of clinical research in the Department of Ophthalmology at Weill Cornell Medical College